[1]
“L-Ornithine-L-Aspartate and Intermittent Renal Replacement Therapy in Fulminant Hepatitis A: A Case Report”, jrenhep, vol. 7, no. 1, pp. 28–33, Mar. 2023, doi: 10.15586/jrenhep.v7i1.154.